Multiply Labs has developed a robotic biomanufacturing cluster that the company claims can reduce the cost of cell and gene therapy (CGT) manufacturing by 74%. The modular system achieves this by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback